1. Balto JM, Pilutti LA, Motl RW. Loneliness in Multiple Sclerosis: Possible Antecedents and Correlates. Rehabil Nurs J 2019; 44(1): 52-9.
2. Compston A, Lassmann H, McDonald I. The story of multiple sclerosis. McAlpine's Multiple Sclerosis London: Churchill Livingstone. 2006: 3-68.
3. Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S, et al. Effect of comorbidity on mortality in multiple sclerosis. Neurology 2015; 85(3): 240-7.
4. Nasr Z, Majed M, Rostami A, Sahraian MA, Minagar A, Amini A, et al. Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence. Neurological Sci 2016; 37(11): 1759-63.
5. Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Multiple Sclerosis J 2015; 21(3): 305-17.
6. Haussleiter IS, Brüne M, Juckel G. Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord 2009; 2(1): 13-29.
7. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis J 2007; 13(1): 67-72.
8. Askari F, Ghajarzadeh M, Mohammadifar M, Azimi A, Sahraian MA, Owji M. Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex. Acta Med Iran 2014; 52(12): 889-92.
9. Farrell P. It's Not All in Your Head:" Anxiety, Depresson, Mood Swings, and MS: Demos Medical Publishing; 2010.
10. Thornton E, Tedman S, Rigby S, Bashforth H, Young C. Worries and concerns of patients with multiple sclerosis: development of an assessment scale. Multiple Sclerosis J 2006; 12(2): 196-203.
11. Marrie RA, Horwitz R, Cutter G, Tyry T. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand 2012; 125(3): 180-6.
12. Janssens AC, Van Doorn P, De Boer J, Kalkers N, van der Meché FG, Passchier J, et al. A nxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple Sclerosis J 2003; 9(4): 397-403.
13. T Jock Murray M. Multiple sclerosis: the history of a disease: Demos medical publishing; 2004.
14. Sherman DW, Norman R, McSherry CB. A comparison of death anxiety and quality of life of patients with advanced cancer or AIDS and their family caregivers. J Assoc Nurses AIDS Care 2010; 21(2): 99-112.
15. Furer P, Walker JR. Death anxiety: A cognitive-behavioral approach. J Cognitive Psychotherapy 2008; 22(2): 167.
16. Iverach L, Menzies RG, Menzies RE. Death anxiety and its role in psychopathology: Reviewing the status of a transdiagnostic construct. Clin Psychol Review 2014; 34(7): 580-93.
17. Nordin L, Rorsman I. Cognitive behavioural therapy in multiple sclerosis: a randomized controlled pilot study of acceptance and commitment therapy. J Rehabilitation Med 2012; 44(1): 87-90.
18. Sussman JC, Liu WM. Perceptions of two therapeutic approaches for palliative care patients experiencing death anxiety. Palliative Supportive care. 2014; 12(4): 251-60.
19. Yalom ID. Staring at the sun: Overcoming the terror of death. Humanistic Psychologist 2008; 36(3-4): 283.
20. Norton PJ, Price EC. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nervous Mental Dis 2007; 195(6): 521-31.
21. Deacon BJ, Abramowitz JS. Cognitive and behavioral treatments for anxiety disorders: A review of meta‐analytic findings. J Clin Psychol 2004; 60(4): 429-41.
22. Arch JJ, Eifert GH, Davies C, Vilardaga JCP, Rose RD, Craske MG. Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. J Consulting Clin Psychol 2012; 80(5): 750.
23. Hayes SC. Climbing our hills: A beginning conversation on the comparison of acceptance and commitment therapy and traditional cognitive behavioral therapy. Clinical Psychology: Sci Practice 2008; 15(4): 286-95.
24. Pakenham KI, Fleming M. Relations between acceptance of multiple sclerosis and positive and negative adjustments. Psychol Health 2011; 26(10): 1292-309.
25. Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: Model, processes and outcomes. Behav Res Therapy 2006; 44(1): 1-25.
26. Eifert GH, Forsyth JP, Arch J, Espejo E, Keller M, Langer D. Acceptance and commitment therapy for anxiety disorders: Three case studies exemplifying a unified treatment protocol. Cognitive Behav Practice 2009; 16(4): 368-85.
27. Bach PA, Moran DJ. ACT in practice: Case conceptualization in acceptance and commitment therapy: New Harbinger Publications; 2008.
28. Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA, Petkus AJ, et al. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain 2011; 152(9): 2098-107.
29. Angiola JE, Bowen AM. Quality of life in advanced cancer: An acceptance and commitment therapy view. Counseling Psychologist 2013; 41(2): 313-35.
30. Eifert GH, Forsyth JP. Acceptance and commitment therapy for anxiety disorders: A practitioner's treatment guide to using mindfulness, acceptance, and values-based behavior change: New Harbinger Publications; 2005.
31. Ruiz FJ. A review of Acceptance and Commitment Therapy (ACT) empirical evidence: Correlational, experimental psychopathology, component and outcome studies. International J Psychol Psychological Therapy 2010; 10(1).
32. Molavi P, Mikaeili N, Rahimi N, Mehri S. The effectiveness of acceptance and commitment therapy based on reducing anxiety and depression in students with social phobia. J Ardabil Univ Med Sci 2014; 14(4): 412-23. [in Persian]
33. Powers MB, Vörding MBZVS, Emmelkamp PM. Acceptance and commitment therapy: A meta-analytic review. Psychother Psychosom 2009; 78(2): 73-80.
34. Bradaran M, Zare, H, Ali Pour, A, Farzad, W . Comparison of the effectiveness of treatment based on commitment and acceptance and motivational interviewing on reducing anxiety, depression, psychological pressure and increasing the hope of patients with essential hypertension. Clin Psychol Psychotherapy 2017; 8(4): 95-105.
35. Harris R. ACT made simple: An easy-to-read primer on acceptance and commitment therapy: New Harbinger Publications; 2009.
36. Pak R, Abdi R, Chalbianloo G. Effectiveness of acceptance and commitment therapy (ACT) on disease acceptance and experiential avoidance in patients with multiple sclerosis: Contemporary Psychology 2017; 12(1): 63-72. [in Persian]
37. Amir F, Ahadi H, Nikkhah K, Seirafi M. The effectiveness of acceptance and commitment group therapy and group logotherapy in reducing perceived stress among MS patients. Caspian J Neurol Sci 2017; 3(11): 175-84.
38. Rajabi S, Yazdkhasti F. The Effectiveness of Acceptance and Commitment Group Therapy on Anxiety and Depression in Women with MS Who Were Referred to the MS Association. J Clin Psycol 2014; 21(1): 29-38.
39. Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. A persian translation of the structured clinical interview for diagnostic and statistical manual of mental disorders: psychometric properties. Comprehensive Psychiatry 2009; 50(1): 86-91. [in Persian]
40. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the penn state worry questionnaire. Behav Res Therapy 1990; 28(6): 487-95.
41. Borjali A, Sohrabi F, Dehshiri GR, Golzari M. Psychometrics particularity of farsi version of Pennsylvania state worry questionnaire for college students. Appl Psychol 2010; 4(1): 67-75.
42. Gillanders DT, Bolderston H, Bond FW, Dempster M, Flaxman PE, Campbell L, et al. The development and initial validation of the cognitive fusion questionnaire. Behav Therapy 2014; 45(1): 83-101.
43. Soltani E, Momenzadeh S, Hoseini SZ, Bahrainian SA. Psychometric properties of the cognitive fusion questionnaire. Pajoohandeh J 2016; 21(5): 290-7. [in Persian]
44. Beck AT, Steer RA. Manual for the Beck anxiety inventory. San Antonio, TX: Psychological Corporation. 1990.
45. Kaviani H, Mousavi A. Psychometric properties of the Persian version of Beck Anxiety Inventory (BAI). Tehran Univ Med J TUMS Publications 2008; 66(2): 136-40. [in Persian]
46. Framework IC. The MOS 36-item short-form health survey (SF-36). Med Care 1992; 30(6): 473-83.
47. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005; 14(3): 875-82. [in Persian]
48. Asghari A, Faghehi S. Validation of the SF-36 health survey questionnaire in two Iranian samples. J Daneshvar Raftar 2003; 1: 1-11.
49. Brinkborg H, Michanek J, Hesser H, Berglund G. Acceptance and commitment therapy for the treatment of stress among social workers: A randomized controlled trial. Behav Res Therapy 2011; 49(6-7): 389-98.
50. Zettle RD, Rains JC, Hayes SC. Processes of change in acceptance and commitment therapy and cognitive therapy for depression: A mediation reanalysis of Zettle and Rains. Behav Modification 2011; 35(3): 265-83.
51. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: The process and practice of mindful change: Guilford Press; 2011.
52. Sheppard SC, Forsyth JP, Hickling EJ, Bianchi J. A novel application of acceptance and commitment therapy for psychosocial probleMS associated with multiple sclerosis: Results from a half-day workshop intervention. Int J MS Care 2010; 12(4): 200-6.
53. Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005; 162(6): 1171-8.
54. Schreier AM, WilliaMS SA, editors. Anxiety and quality of life of women who received radiation or chemotherapy for breast cancer. Oncol Nurs Forum 2004; 31(1): 127-30.